Cargando…
ODP441 NErbB-2 and Androgen Receptor Regulate a Gene Signature Involved in Immune Response and Favorable Outcome in TNBC
Triple negative breast cancer (TNBC) has poor prognosis and neither established biomarkers nor therapeutic targets. On the one hand, the androgen receptor (AR), a steroid hormone receptor (SR) which is expressed in 10-53% of TNBC and proved to be critical for BC proliferation, has been proposed as a...
Autores principales: | Elizalde, Patricia, Roldan Deamicis, Agustina, Oakley, Robert, Madera, Santiago, Cordo Russo, Rosalía, Schillaci, Roxana, Fresno, Cristóbal, Cidlowski, John, Proietti, Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627629/ http://dx.doi.org/10.1210/jendso/bvac150.1483 |
Ejemplares similares
-
ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer
por: Elizalde, Patricia, et al.
Publicado: (2022) -
Androgen Receptor Highjacks ErbB-2 Nuclear Function to Induce Triple Negative Breast Cancer Growth
por: Deamicis, Agustina Roldán, et al.
Publicado: (2021) -
OR12-02 When the Glucocorticoid Receptor Meets the Mineralocorticoid Receptor in the Nucleus of Human Cells
por: Petrillo, Maria G, et al.
Publicado: (2020) -
SUN-007 Discovery of Novel Signaling Pathways Downstream of PTK6 in TNBC Models
por: Dwyer, Amy, et al.
Publicado: (2019) -
AR Is Not an Independent Marker for TNBC: The Lesson We Learn From Two PDX Models
por: Wang, Xiaoqiang, et al.
Publicado: (2021)